RCEL · AVITA Medical, Inc.
$4.44
-0.17 (-3.69%)
At close · Jul 29
Going-concern doubt
— flagged May 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on the Company's liquidity position and the Company's current forecast of operating results and cash flows, management determined there is substantial doubt about the Company's ability to continue as a going concern over the next twelve months following the date of issuance of these Consolidated Financial Statements due to the Company's debt repayment obligations, recurring losses, and historical negative cash flows.”View the 10-Q filed May 14, 2026
Market Cap
$141.88M
Shares
30.78M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$4.44
Open$4.61
Day$4.37–4.68
52W$3.22–7.12
Avg vol 30d342K
Short int2.6M · 8.5% float · 7.8d
Short vol50%
Last earningsMay 14, 2026
DataJan 2020–Jul 2026
Filing10-Q · May 14
Up next
Next earnings call
Aug 13, 2026
Est · unconfirmed
· in 2 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 14, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Neutral
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 20.7 · elevated
Equity put/call 0.61
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+6%
above
Price vs 50-day avg
+2%
above
RSI (14)
47
neutral
MACD trend
Negative
52-week position
31%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+8%
trailing
6-month return
+9%
trailing
YTD return
+29%
this year
Relative strength
+3%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $4 › 200d $4 — 50d above 200d
Institutional flow
Distributing
19 of 79 funds reported for Jun 30 · net -15.1K sh shares · +2 new
Insider flow
Accumulating
Net +$205.6K over 90 days · 0% sells
Short interest
Rising
8.50% of float · ▲ +3.4% MoM · 7.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
79 holders — mid 3-yr range
Squeeze score
80
high risk · 0–100
Fundamentals
Revenue growth
+11%
Y/Y
Gross margin
82%
contracting
EPS growth
+27%
Y/Y
Free cash flow
$-32.2M
Balance sheet
$32.7M
net debt
Quant / Vol
risk profile
Volatility
91%
annualized · 1-yr
Max drawdown
−52%
past year
ATR
8.3%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed May 14, 2026
Total revenue
· Full year 2026
Initiated
$80M – $85M
prior FY $71.61M
midpoint +15.2% Y/Y
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+6%
Bullish
Price vs 50-day avg
+2%
Bullish
RSI (14)
47
Neutral
MACD trend
Negative
Bearish
52-week position
31%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $4 › 200d $4 — 50d above 200d
Institutional flow
Distributing
19 of 79 funds reported for Jun 30 · net -15.1K sh shares · +2 new
Insider flow
Accumulating
Net +$205.6K over 90 days · 0% sells
Short interest
Rising
8.50% of float · ▲ +3.4% MoM · 7.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
79 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $3
Now $4 · 31%
52-wk high $7
vs 200-day avg +6%
vs 50-day avg +2%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
RCEL
this stock
AVITA Medical, Inc.
|
$141.88M | +28.7% | +11.5% | — | 8.5% |
|
ABT
Abbott Laboratories
|
$188.12B | -13.4% | +5.7% | 30.3 | 1.4% |
|
SYK
Stryker Corp
|
$132.87B | +0.5% | +11.2% | 40.1 | 1.8% |
|
MDT
Medtronic plc
|
$111.21B | -8.1% | +8.4% | 23.3 | 1.5% |
|
BSX
Boston Scientific Corp
|
$68.43B | -51.7% | +5.5% | 19.3 | 1.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| RCEL | -10.1% | +7.5% | +8.8% | +7.5% | +28.7% |
| SPY | -2.4% | -2.3% | +6.3% | -2.3% | +7.0% |
| vs SPY | -7.7% | +9.8% | +2.5% | +9.8% | +21.7% |